Atara Biotherapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Atara Biotherapeutics Inc
TickerATRA
CIK #0001604464
CUSIP046513107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address3260 Bayshore Boulevard, Brisbane, CA 94005
Source [EDGAR]
CIK Filing 2011 - 2025
[0001604464] 10-K
[0001604464] 10-Q
[0001604464] 3
[0001604464] 4
[0001604464] 8-K
[0001604464] SC 13D
[0001604464] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Redmile Group LLC Atara Biotherapeutics Inc [2025-05-23] 0.0
Panacea Innovation Ltd Atara Biotherapeutics Inc [2025-05-21] 0.0
Panacea Innovation Ltd Atara Biotherapeutics Inc [2025-02-06] 0.0
Adiumentum Capital Fund I LP Atara Biotherapeutics Inc [2024-05-22] 6.7
Citadel Advisors LLC Atara Biotherapeutics Inc [2024-03-18] 6.4
EcoR1 Capital LLC Atara Biotherapeutics Inc [2023-11-21] 0.9
Wasatch Advisors Inc Atara Biotherapeutics Inc [2023-02-08] 8.8
Goldman Sachs Group Inc Atara Biotherapeutics Inc [2023-02-07] 6.4
State Street Corp Atara Biotherapeutics Inc [2023-02-03] 8.06
FMR LLC Atara Biotherapeutics Inc [2022-02-09] 0.0
Point72 Asset Management LP Atara Biotherapeutics Inc [2021-12-21] 5.1
JPMorgan Chase & Co Atara Biotherapeutics Inc [2021-01-08] 7.3
Maverick Capital Ltd Atara Biotherapeutics Inc [2020-02-14] 9.2
Bridger Management LLC Atara Biotherapeutics Inc [2019-11-01] 5.5
Camber Capital Management LP Atara Biotherapeutics Inc [2019-07-29] 2013.0
Vanguard Group Inc Atara Biotherapeutics Inc [2019-02-11] 6.16
Camber Capital Management LLC Atara Biotherapeutics Inc [2018-01-05] 2013.0
Morgan Stanley Atara Biotherapeutics Inc [2017-12-07] 5.0
Bridger Management LLC Atara Biotherapeutics Inc [2017-04-21] 5.2
Arrowpoint Asset Management LLC Atara Biotherapeutics Inc [2017-02-13] 5.4
BlackRock Inc Atara Biotherapeutics Inc [2017-01-30] 6.0
Redmile Group LLC Atara Biotherapeutics Inc [2016-02-16] 5.36
FMR LLC Atara Biotherapeutics Inc [2016-02-12] 0.0
Amgen Inc Atara Biotherapeutics Inc [2015-04-01] 9.0
Kleiner Perkins Caufield & Byers XV LLC Atara Biotherapeutics Inc [2015-02-17] 12.9
HELU Carlos SLIM Atara Biotherapeutics Inc [2015-02-17] 6.6
DAG Ventures V-QP LP Atara Biotherapeutics Inc [2015-02-17] 9.4
Ciechanover Isaac E Atara Biotherapeutics Inc [2015-02-13] 5.3
Celgene Corp /DE/ Atara Biotherapeutics Inc [2015-02-13] 9.0
FMR LLC Atara Biotherapeutics Inc [2015-02-13] 0.0
Domain Partners VIII LP Atara Biotherapeutics Inc [2015-02-05] 10.6
Baupost Group LLC/MA Atara Biotherapeutics Inc [2014-11-10] 12.86
Form 3/4/5 Filer 2011 - 2025
Nguyen AnhCo
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
Panacea Innovation Ltd
Huang James
Mallik Ameet
Gallagher Carol Giltner
Heiden William K
Fust Matthew K
Touchon Pascal
Roncarolo Maria Grazia
Green Jeremy
Redmile Group, LLC
Subramanian Nachiappan
Adiumentum Capital Fund I GP LLC
Adiumentum Capital Fund I LP
Ciongoli Gregory Austin
Hyllengren Eric J
Henrich Jill
Murugan Amar
Joshi Manher
Dobmeier Eric
Seidenberg Beth C
Banard Charlene A.
Dupont Jakob
Koppikar Utpal
Renaud Ronald C JR
Baynes Roy D.
Yarema Kristin
Newell Joe
Ciechanover Isaac E.
Berger Dietmar
Kim Mina
Porter Derrell
Marcus Joel S
Haqq Christopher
Soffer Gad
Clark Mitchall G.
McGrath John
Turner Heather D
Kleiner Perkins Caufield & Byers XV, LLC
KPCB XV Associates, LLC
KPCB XV Founders Fund, LLC
Weber Eckard
DAG Ventures V-QP, L.P.
DAG Ventures V, L.P.
Chung Young J.
Pianim Nicholas K.
Goodrich R. Thomas
Williams Greg
DAG Ventures Management V, LLC
Cadeddu John J.
Blair James C
Treu Jesse I
Vitullo Nicole
Schoemaker Kathleen K
DP VIII Associates, L.P.
Dovey Brian H
Halak Brian K
Domain Partners VIII, L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
EcoR1 Capital LLC [2025-06-30] SOLE 573,183 573,183
Redmile Group LLC [2025-06-30] SOLE 441,701 441,701
Vanguard Group Inc [2025-06-30] SOLE 0 189,305
Vestal Point Capital LP [2025-06-30] SOLE 94,085 94,085
Staley Capital Advisers Inc [2025-06-30] SOLE 75,000 75,000
BlackRock, Inc. [2025-06-30] SOLE 70,848 70,848
Acadian Asset Management LLC [2025-06-30] DFND 65,155 65,155
Geode Capital Management LLC [2025-06-30] DFND 60,136 60,136
Marshall Wace LLP [2025-06-30] OTR 0 42,355
State Street Corp [2025-06-30] DFND 25,253 25,253
Citadel Advisors LLC [2025-06-30] DFND 23,003 23,003
Mackenzie Financial Corp [2025-06-30] SOLE 22,514 22,514
GSA Capital Partners LLP [2025-06-30] SOLE 19,591 19,591
FMR LLC [2025-06-30] DFND 16,244 17,156
Renaissance Technologies LLC [2025-06-30] SOLE 16,936 16,936
Morgan Stanley [2025-06-30] DFND 14,802 14,926
Bridgeway Capital Management LLC [2025-06-30] SOLE 14,000 14,000
Northern Trust Corp [2025-06-30] DFND 11,147 11,170
UBS Group AG [2025-06-30] DFND 8,385 8,385
Bank of America Corp /DE/ [2025-06-30] DFND 0 7,688
Raymond James Financial Inc [2025-06-30] DFND 0 4,021
Vanguard Group Inc [2025-06-30] DFND 0 1,456
Royal Bank of Canada [2025-06-30] DFND 1,450 1,450
SBI Securities Co., Ltd. [2025-06-30] DFND 1,404 1,404
Wells Fargo & Company/MN [2025-06-30] DFND 0 951
Jones Financial Companies LLLP [2025-06-30] SOLE 703 703
Osaic Holdings Inc [2025-06-30] DFND 0 610
JPMorgan Chase & Co [2025-06-30] DFND 216 216
Raiffeisen Bank International AG [2025-06-30] SOLE 200 200
Banque Transatlantique SA [2025-06-30] DFND 0 176
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com